Targeting the a1 domain to perturb semaphorin 3A binding may reduce myeloid cell migration to hypoxic tumor areas and may offset their M2-polarization all while also enhancing the cytolytic function of cytotoxic T cells. This evidence concerns the gene SEMA3A and neoplasm.